WO2010063937A1 - Procede de fabrication d'une serie de capsules, et serie de capsules associee - Google Patents
Procede de fabrication d'une serie de capsules, et serie de capsules associee Download PDFInfo
- Publication number
- WO2010063937A1 WO2010063937A1 PCT/FR2009/052351 FR2009052351W WO2010063937A1 WO 2010063937 A1 WO2010063937 A1 WO 2010063937A1 FR 2009052351 W FR2009052351 W FR 2009052351W WO 2010063937 A1 WO2010063937 A1 WO 2010063937A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solution
- liquid
- surfactant
- polyelectrolyte
- capsules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to a method of manufacturing a series of capsules, each capsule comprising a liquid body containing at least a first product and a gelled envelope completely encapsulating the core, the method comprising the following steps:
- each drop comprising a central core formed of the first solution and a peripheral film formed of second solution and completely covering the central core;
- Such capsules which comprise a liquid core encapsulated by a substantially solid gelled envelope, have applications in many technical fields.
- these capsules are used to contain various additives that improve the properties of a food product, such as its taste, or its shelf life.
- the aforementioned capsules are in particular filled with biologically or cosmetically active products. They are used in particular to protect their contents and control the release of the product they contain.
- Such capsules are also used in biochemical applications to immobilize cells in bioreactors or as artificial cells in implants.
- the capsule casings are generally formed of a biocompatible material with the human body.
- the shell with polymers such as polysaccharides, which are biocompatible, biodegradable and in most cases non-toxic.
- polysaccharides which are biocompatible, biodegradable and in most cases non-toxic.
- these polymers can advantageously pass from a liquid state in solution to a substantially more viscous state to form a gel ensuring mechanical retention of the liquid contained in the capsule.
- alginates are used in particular to create heart-envelope structures in which the heart is liquid.
- the solid precursor nucleus is dissolved and the liquid product to be encapsulated is impregnated inside the bark.
- the second solution contains a clean thermally gelable polymer which is contacted with a high temperature bath to form a gel on the surface of the capsule.
- a clean thermally gelable polymer which is contacted with a high temperature bath to form a gel on the surface of the capsule.
- An object of the invention is therefore to obtain a method of manufacturing a series of capsules having thin envelopes and very controlled structure encapsulating a liquid core, this method being simple and effective to implement.
- the subject of the invention is a process of the aforementioned type, characterized in that the second solution contains at least one surfactant prior to its contact with the first solution.
- the method according to the invention may comprise one or more of the following characteristics, taken alone or in any combination (s) technically possible (s):
- the or each surfactant is chosen from an anionic surfactant, a cationic surfactant, a nonionic surfactant or mixtures thereof;
- the surfactant is chosen from an alkyl sulphate, an alkyl sulphonate, an alkylarylsulphonate, an alkaline alkylphosphate, a dialkylsulphosuccinate, an alkaline earth salt of saturated or unsaturated fatty acids, an alkylpyridium halide salt or alkylammonium such as n-ethyldodecylammonium chloride or bromide, cetylammonium chloride or bromide, polyoxyethylenated and / or polyoxypropylenated derivatives of fatty alcohols, fatty acids or alkylphenols, or of arylphenols, alkyls glucosides, polysorbates cocamides or mixtures thereof;
- the total weight percentage of surfactant in the second solution is greater than 0.01% and is advantageously between 0.01% and 0.5% by weight;
- the or each polyelectrolyte is a polyelectrolyte reactive with multivalent ions, in particular a polysaccharide reactive with multivalent ions such as an alkaline alginate, a gelane or a pectin;
- the ion-reactive polyelectrolyte is an alkaline alginate advantageously having an ⁇ -L-guluronate block content of greater than 50%, especially greater than 55%;
- the mass content of polyelectrolyte in the second solution is less than 5% by weight and is advantageously between 0.5 and 3% by weight;
- the ratio of the flow rate of the first solution to the flow rate of the second solution at the outlet of the jacket is between 1 and 200, advantageously between 10 and 200, the gelled envelope having a thickness of between 0.1% and 10%; %, advantageously between 0, 1% and 2% of the diameter of the capsule, after recovery of the capsules formed; and
- the first solution comprises at least one biologically active product, a cosmetic product or an edible product suitable for consumption.
- the invention also relates to a series of capsules, each capsule comprising a liquid core containing at least a first product, and a gelled envelope completely encapsulating the liquid core at its periphery, the gelled envelope being adapted to retain the liquid heart when the capsule is immersed in a gas, the gelled envelope comprising at least one gelled polyelectrolyte; characterized in that the gelled envelope further comprises at least one surfactant.
- the invention also relates to the use of a series of capsules as defined above as a dosage unit of a cosmetic, dermatological or parapharmacological product.
- the invention further relates to the use of a series of capsules as defined above as a flavor pearl containing a food product or as a bomb of sweetness to be added to a drink.
- the invention also relates to the use of a series of capsules as defined above as a reservoir for the growth of cells to perform disease detection tests or to form a bioreactor.
- a series of capsules as defined above as a reservoir for the growth of cells to perform disease detection tests or to form a bioreactor.
- FIG. 1 is a schematic sectional view along a median vertical plane of a first capsule manufacturing device according to the invention, during the manufacture of a series of capsules according to the invention; 2 is a view on a larger scale, in section along a median vertical plane of a capsule according to the invention manufactured by the method shown in FIG.
- FIG. 3 is a view similar to Figure 1 of a detail of a second capsule manufacturing device according to the invention
- - Figure 4 is a view, taken in section along a median vertical plane, of a third device for producing capsules according to the invention.
- each capsule 10 comprises a liquid core 12 and a gelled outer shell 14 surrounding the entire outer surface of the core 12 to retain the liquid heart 12.
- each capsule 10 is spherical in shape and advantageously has an outside diameter of less than 5 mm and in particular between 1 mm and 3 mm.
- the liquid heart 12 contains at least a first product advantageously chosen from a biologically active product, a cosmetic product, or an edible product suitable for consumption.
- the first product is a biologically active product
- it is advantageously chosen from anticoagulants, anti-thrombogenic agents, antimitotic agents, anti-proliferation agents, anti-adhesion agents, anti-migration agents, cell adhesion promoters and growth factors.
- antiparasitic molecules anti-inflammatory drugs, angiogenic agents, angiogenesis inhibitors, vitamins, hormones, proteins, antifungals, antimicrobial molecules, antiseptics or antibiotics.
- the liquid core 12 contains reagents such as proteins or reagents to form a bioreactor, or to form artificial cells for implants.
- a cosmetic product that may be contained in the heart is for example cited in Council Directive 93/35 / EEC dated June 14, 1993.
- This product is for example a cream, an emulsion, a lotion, a gel and an oil for skin (hands, face, feet, etc.), a foundation (liquid, paste) a preparation for baths and showers (salts, mousses, oils, gels, etc.), a hair care product (hair dyes and bleaches ), a cleaning product (lotions, powders, shampoos), a hair care product (lotions, creams, oils), a styling product (lotions, lacquers, glossines), a product for shaving (soaps, mousses, lotions, etc.), a product intended to be applied to the lips, a sun product, a sunless tanning product, a product for whitening the skin, an anti-wrinkle product.
- the edible products that are suitable for consumption by a human being or an animal are advantageously purees of vegetables or fruits such as mashed mango, pear puree, coconut puree, onion cream, leeks, carrots, or other preparations that can mix several fruits or vegetables.
- oils such as a food oil, such as olive oil, soybean oil, grape seed oil, sunflower oil, or any other oil extracted from the plants.
- the core 12 is advantageously in the form of a first pure liquid product, a solution of the or each first product in a liquid solvent, a dispersion such as an emulsion or a suspension of the or each first product. in a liquid.
- the viscosity of the liquid core 12 is less than 2000 mPa.s.
- the liquid core 12 is based on a predominantly aqueous phase or on the contrary a predominantly oily phase.
- the gelled envelope 14 of the capsules 10 according to the invention comprises a gel containing water and at least one polyelectrolyte reactive with multivalent ions. According to the invention, the envelope 14 further contains a surfactant resulting from its manufacturing process, as will be described in detail below.
- polyelectrolyte reactive with polyvalent ions means a polyelectrolyte capable of passing from a liquid state in an aqueous solution to a gelled state under the effect of contact with a gelling solution containing multivalent ions such as ions of an alkaline earth metal selected for example from calcium ions, barium ions, magnesium ions.
- the individual polyelectrolyte chains are substantially free to flow relative to one another.
- An aqueous solution of 2% by weight of polyelectrolyte then exhibits a purely viscous behavior at the shear gradients characteristic of the forming process.
- the viscosity of this zero shear solution is between 50 mPa.s and 10,000 mPa.s, advantageously between 3000 mPa.s and 7000 mPa.s.
- the individual polyelectrolyte chains in the liquid state advantageously have a molar mass greater than 65000 g / mol.
- the individual polyelectrolyte chains together with the multivalent ions form a coherent three-dimensional network which holds the liquid core and prevents its flow.
- the individual chains are held together and can not flow freely relative to each other.
- the viscosity of the formed gel is infinite.
- the gel has a threshold of stress to the flow. This stress threshold is greater than 0.05 Pa.
- the gel also has a modulus of elasticity that is non-zero and greater than 35 kPa.
- the three-dimensional gel of polyelectrolyte contained in the envelope 14 traps water and the surfactant.
- the mass content of the polyelectrolyte in the envelope 12 is for example between 0.5% and 5%.
- the polyelectrolyte is preferably a biocompatible polymer that is harmless to the human body. It is for example produced biologically.
- polysaccharides synthetic polyelectrolytes based on acrylates (sodium, lithium, potassium or ammonium polyacrylate, or polyacrylamide), synthetic polyelectrolytes based on sulfonates (poly (styrene sulfonate)). sodium, for example). More particularly, the polyelectrolyte is selected from an alkaline earth alginate, such as sodium alginate or potassium alginate, gellan or pectin.
- Alginates are produced from brown algae called “laminar”, referred to as “sea weed”.
- Such alginates advantageously have an ⁇ -L-guluronate content of greater than about 50%, preferably greater than 55%, or even greater than 60%.
- the surfactant is preferably an anionic surfactant, a nonionic surfactant, a cationic surfactant or a mixture thereof.
- the molecular weight of the surfactant is between 150 g / mol and 10,000 g / mol, advantageously between 250 g / mol and 1500 g / mol.
- the surfactant is an anionic surfactant, it is for example chosen from an alkyl sulphate, an alkyl sulphonate, an alkyl aryl sulphonate, an alkaline alkyl phosphate, a dialkyl sulphosuccinate, an alkaline earth salt of saturated or unsaturated fatty acids.
- surfactants advantageously have at least one hydrophobic hydrocarbon chain having a number of carbons greater than 5 or even 10 and at least one hydrophilic anionic group, such as a sulphate, a sulphonate or a carboxylate linked to one end of the hydrophobic chain.
- the surfactant is a cationic surfactant
- it is, for example, chosen from an alkylpyridium or alkylammonium halide salt such as n-ethyldodecylammonium chloride or bromide, cetylammonium chloride or bromide.
- CTLAB CTL-C quaternary ammonium cation
- surfactant is a nonionic surfactant, it is for example chosen from polyoxyethylenated and / or polyoxypropylenated derivatives of fatty alcohols, fatty acids, or alkylphenols, arylphenols, or from alkyls glucosides, polysorbates, cocamides .
- the mass content of surfactant in the shell is greater than 0.001% and is advantageously greater than 0.1%.
- the envelope 14 consists exclusively of polyelectrolyte, surfactant, and water. The sum of the mass contents of polyelectrolyte, surfactant, and water is then equal to 100%.
- the method of manufacturing the capsules 10 according to the invention is implemented in a manufacturing device 30 according to the invention, shown in FIG. 1.
- the manufacturing device 30 comprises a double envelope 32 for coextruding a series of drops intended to forming capsules 10, means 34 for feeding into the double envelope 32 of a first solution 36 intended to form the liquid core 12, and means 38 for feeding into the double envelope 32 a second solution 40 intended to
- the device 30 further comprises a gelling bath 41A disposed under the jacket 32 and a bath 41 B for rinsing and storage.
- the double jacket 32 comprises an inner tube 42 defining a central chamber 44 for circulating the first solution 36, and an outer tube 46 defining, with the inner tube 42, an annular chamber 48 for circulating the second solution 40 .
- the inner tube 42 and the outer tube 46 extend coaxially along a vertical axis A-A '. They open downwards through a formation opening 50 of each drop.
- the inner tube 42 advantageously has a diameter greater than 0.5 mm and substantially between 0.6 mm and 2 mm.
- the outer tube 46 has a diameter greater than the inner tube 42 of at least 0.2 mm, preferably at least 0.4 mm.
- the maximum diameter of the outer tube 46 is less than 5 mm.
- Each tube 42, 46 has a convergent cross-section downwardly in the vicinity of the opening 50.
- the means 34 for supplying the first solution 36 comprise a first pump 52 for dispensing the first solution 36, hydraulically connected downstream to the central chamber 44 via a first conveyance line 54.
- the first pump 52 is advantageously a syringe pump capable of controlling a given injection rate Q1 of the first solution 36 in the central chamber of between 1 ml / h and 120 ml / h, preferably in the range of between 50 ml / h. h and 80 ml / h.
- the supply means 38 of the second solution 40 comprise a second pump 56 for dispensing the second solution 40, connected downstream to the annular chamber 48 via a second conveyance pipe 58.
- the second pump 56 is advantageously a syringe pump capable of controlling the injection flow rate Q2 of the second solution 40 in the annular chamber 48 that this flow rate Q2 is between 0.005 times and 0.2 times the flow rate Q1 controlled by the first pump 52
- the first solution 36 is formed by the or each first pure liquid product, a solution of the or each first product in a liquid solvent, a dispersion such as an emulsion or a suspension of the or each first product in a liquid such as described above.
- the second solution contains the liquid polyelectrolyte suitable for gelling intended to form the liquid envelope 12, water and, in addition, according to the invention, at least one surfactant for producing the capsules 10.
- the polyelectrolyte has been described in detail above and will not be redescribed. It is totally dissolved in the water forming the second solution.
- the mass content of the polyelectrolyte in the second solution is greater than the mass content of the polyelectrolyte in the envelope 14. In the second solution, this mass content is greater than 0.1% and is for example between 0.1% and 5% by weight of the second solution.
- the or each surfactant has been described above.
- the mass content of surfactant is between 0.01% and 1% by weight of the total mass of the second solution.
- the concentration of surfactant in the second solution is advantageously between 0.01% and 0.5% by weight. If the composition of the liquid core 12 is predominantly oily, the concentration of surfactant is between 0.1% and 0.5% by weight.
- the surfactant mass concentration is about 0.03% for an aqueous liquid heart and is about 0.15% for an oily liquid body.
- the second solution is prepared by dissolving the surfactant in the amount of water needed to form the second solution. Then, the polyelectrolyte is added to the surfactant solution in water and is mixed with a magnetic bar for a given time, for example at least 24 hours, at room temperature.
- the 41A bath contains a gelling solution 70.
- the solution 70 is for example an aqueous solution of a reactant X l m n where X is preferably a halide ion such as chloride ion, bromide ion, iodide ion or a fluoride ion, and I is preferably a multivalent cation of an alkaline earth such as calcium, magnesium, or barium, and n and m are greater than or equal to 1.
- the multivalent ions present in the gelling solution 70 thus formed are able to react with the polyelectrolyte to form bonds between the different polyelectrolyte chains present in the second solution, when the second solution comes into contact with the gelling solution 70.
- the concentration of reagent in the gelling solution is advantageously between 5% and 20% by weight.
- the bath 41A is disposed below and away from the opening 50, so that the drops formed by coextrusion in the jacket 32 fall spontaneously by gravity through a volume of air in the gelling solution 70 where they are submerged.
- the rinsing bath 41 B comprises a rinsing and storage solution consisting essentially of water.
- This method comprises a step of forming a drop 78 comprising a core 80 of the first solution and an outer film 82 of the second solution by coextrusion in the device 32.
- the method then comprises a step of dipping the drop 78 in the bath of gelation 41A, followed by a rinsing / storage step in the rinse bath 41 B.
- first solution 36 and the second solution 40 are prepared as described above with the weight loads of polyelectrolyte and surfactant described above.
- the first pump 52 is activated to convey a continuous stream of first solution 36 through the central chamber 44 with a calibrated flow rate Q1 advantageously between 10 ml per hour and 80 ml per hour, as seen above.
- the second pump 56 is activated to simultaneously convey a continuous flow of second solution 40 through the annular space 48 at a flow rate Q2 controlled for example between 0.005 times and 0.2 times the flow rate Q1 of the first solution 36.
- the relative adjustment and independent of the flow rates Q1 and Q2 makes it possible to control the thickness of the envelope 14 independently of the outer diameter of the capsule 10.
- a substantially spherical drop 78 is progressively formed with a core 80 composed exclusively of first solution and a thin film 82 of second solution completely surrounding the outer surface of the core 80.
- the core 80 consists exclusively of first solution 36.
- the polyelectrolyte is maintained in its liquid state as in the second solution.
- the drop 78 When the weight of the drop 78 is greater than its capillary retention force on the tubes of the jacket 32, the drop 78 is detached from the jacket 32 by gravity and falls into the gelling bath 41 A. The film 82 is then in contact with the gelling solution. In contact with the multivalent ions from the gelling reagent, the individual polyelectrolyte chains present in the film 82 connect to each other to form a crosslinked network which entraps water and at least partially of the surfactant contained in the second solution.
- a gelled envelope 14 adapted to retain the liquid core 12 of the first liquid solution is thus formed.
- This envelope 14 has a proper mechanical strength, that is to say, it is able to completely surround the liquid heart 12 and retain the liquid in the heart 12 to prevent it from diffusing through the envelope 14, especially when the capsule 10 is disposed in a gas such as ambient air.
- the presence of surfactant in the second solution significantly promotes the formation of the capsules 10, in particular by preventing the film 82 from undergoing detrimental phase separation when it is soaked in the gelling solution 70. Then, another drop 78 is then formed at the lower end 50 of the double jacket 32 and the process steps are then identical to those described above.
- Capsules thus formed thus store various compounds such as biologically active products, proteins, cosmetics, or edible products for consumption by a human or an animal.
- the envelope 12 is broken by shearing, or by mechanical crushing, or by chelation of the multivalent ions, using a suitable salt such as EDTA, in the case where uses calcium ions to form the gel of the envelope. This rupture makes it possible to recover the first product present in the heart
- the recovered capsules are immersed in a liquid to swell, and then burst by controlling the osmotic pressure through the gelled envelope.
- the opening of the casing 14 then releases the liquid heart 12. This applies in particular to capsules containing a syrup.
- a polymer such as polyethylene glycol with a molecular weight greater than 5,000 g / mol is added to the core.
- the osmotic pressure is controlled to retract the capsules 10 and decrease their diameter. It is then possible to dry or lyophilize the capsules 10.
- magnetic particles may be added in the first solution 36 and / or in the second solution 40, to modify the handling of the eggs.
- flakes are added in the first solution 36 and / or in the second solution 40 to generate an optical effect on the capsules 10.
- FIG. 3 An alternative embodiment of the capsule manufacturing device 10 is illustrated in FIG. 3.
- this device comprises, around the double jacket 32, an external gas injection envelope 90. extending annularly around and away from the outer tube 46.
- the outer casing 90 opens axially around the opening 50. It is connected to a pressurized gas source to create, around the drop 78 in formation, a gas flow directed downwards.
- the flow rate of this gas flow can be adjusted to control the size of the drops 78 formed at the outlet of the jacket 32.
- the capsule manufacturing method 10 using the device 30 according to FIG. 3 differs just from the method implemented with the device 30 of FIG. 1 in that the size of the drops 78 can be adjusted by regulating the flow of gas.
- Figure 4 illustrates a third capsule forming device 30 which comprises a plurality of double envelopes 32 arranged in parallel next to one another.
- the supply means 34 of the first solution 36 comprise, at the end of the first conduit 54 a common distributor 96 of first solution, into which each central chamber 44 opens double envelopes 32 connected in parallel.
- the supply means 38 of the second solution 40 comprise a common distributor 98 of second solution 40 opening in each annular chamber 48 double envelopes 32 connected in parallel.
- this device 30 allows to form in parallel a number of drops equal to the number of double envelopes 32 mounted in parallel which increases the overall productivity of the device.
- this emulsion can be manufactured by coextrusion within an additional tube placed in the inner tube 42 during the manufacture of the capsule 10. It is thus possible to form hearts 12 containing, for example, vinaigrette.
- first solution and second solution compositions having been used to successfully form capsules according to the invention are described in the table below, in which all percentages are percentages by weight.
- the solvent of the second solution is water.
- PEG is a polyethylene glycol whose molecular weight is also given in the table.
- SDS sodium dodecyl sulfate (anionic surfactant)
- CTAB Cetyl Trimethylammonium Bromide (cationic surfactant)
- Tween 20 is polyoxyethylene sorbitan monolaurate (nonionic surfactant)
- Tween 80 is polyoxyethylenated mono-oleate sorbitan (nonionic surfactant).
- composition for capsules before an aqueous core using anionic surfactant 20 g of sodium alginate, 1000 g of water and 0.3 g of SDS are prepared. SDS and sodium alginate are then added to the solution. The solution is mixed for at least 24 hours to ensure that the alginate is completely dissolved and the solution is homogeneous.
- composition for capsules with an oily heart using anionic surfactant is provided.
- composition for capsules with an aqueous core using a cationic surfactant 20 g of sodium alginate, 1000 g of water and 1.5 g of SDS are prepared. SDS is dissolved in water and sodium alginate is then added. The solution is mixed for at least 24 hours to ensure that the alginate is completely dissolved and the solution is homogeneous.
- composition for capsules having an oily heart using a cationic surfactant 20 g of sodium alginate, 1000 g of water and 1.8 g of CTAB are prepared.
- the CTAB is dissolved in water and the sodium alginate is then added.
- the solution is mixed for at least 24 hours to ensure that the alginate is completely dissolved and the solution is homogeneous. Preparation of the first solution
- the heart solution can be either aqueous or oily. It can contain one or more phases.
- This bath can be prepared based on 200 g of calcium chloride dissolved in 1000 g of water. Alternatively, it can be prepared based on 50 g of calcium lactate pentahydrate dissolved in 1000 g of water.
- the capsules 10 prepared by the process according to the invention do not have a detectable amount of surfactant of the second solution.
- the capsule forming method as described above provides uniformly sized capsules. This makes it possible to use them as a dosage unit in the cosmetic, dermatological or pharmacy field.
- the number of capsules to use, the frequency of application of these capsules or ingestion of these capsules and the duration of treatment may vary depending on the characteristics of the person undergoing treatment.
- the capsules 10 can be used with a heart 12 which comprises a moisturizing cream for the skin, various hair treatments, gloss for the lips.
- a heart 12 which comprises a moisturizing cream for the skin, various hair treatments, gloss for the lips.
- flakes can be added in the core 12 or in the envelope 14 of the capsule to obtain optical effects such as gloss, reflections, irradiance.
- the capsules 10 according to the invention can also be used in the food industry to obtain flavor beads.
- formed capsules containing a food product can be used, for example, to form synthetic caviar.
- the capsules can also be used as bombs of sweetness being added to beverages.
- Capsules which contain, for example, a polymer or other product which makes them swell or deflate by osmotic pressure allows to drop a product contained in the heart 12 in the drink or in a liquid dish. Thus, by swelling or deflation of the capsule, it is possible to detonate it to release the product contained in the heart 12.
- the capsules 10 according to the invention can also be used in the biotechnological field as a reservoir for the growth of cells, to carry out biological tests for detecting disease.
- capsules 10 according to the invention it is thus possible to use capsules 10 according to the invention to facilitate screening under different environmental conditions.
- the addition of magnetic particles in the envelope 14 immobilizes cells in the heart 12 of the capsule 12 to form a bioreactor.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Formation And Processing Of Food Products (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/131,971 US9277759B2 (en) | 2008-12-01 | 2009-12-01 | Method for manufacturing capsule series, and related capsule series |
CN200980156111.9A CN102300564B (zh) | 2008-12-01 | 2009-12-01 | 批量制造胶囊的方法及相关的批量胶囊 |
EP09801470.7A EP2370066B1 (fr) | 2008-12-01 | 2009-12-01 | Procede de fabrication d'une serie de capsules, et serie de capsules associee |
BRPI0916506A BRPI0916506A8 (pt) | 2008-12-01 | 2009-12-01 | Processo de fabricação de uma série de cápsulas e série de cápsulas |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0858172A FR2939012B1 (fr) | 2008-12-01 | 2008-12-01 | Procede de fabrication d'une serie de capsules, et serie de capsules associee |
FR0858172 | 2008-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010063937A1 true WO2010063937A1 (fr) | 2010-06-10 |
Family
ID=40822948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2009/052351 WO2010063937A1 (fr) | 2008-12-01 | 2009-12-01 | Procede de fabrication d'une serie de capsules, et serie de capsules associee |
Country Status (6)
Country | Link |
---|---|
US (1) | US9277759B2 (fr) |
EP (1) | EP2370066B1 (fr) |
CN (1) | CN102300564B (fr) |
BR (1) | BRPI0916506A8 (fr) |
FR (1) | FR2939012B1 (fr) |
WO (1) | WO2010063937A1 (fr) |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012089820A1 (fr) | 2010-12-31 | 2012-07-05 | Capsum | Serie de capsules comprenant au moins une goutte de phase interne dans une goutte de phase intermediaire et procede de fabrication associe |
WO2012131043A1 (fr) | 2011-03-31 | 2012-10-04 | Capsum | Module de mise en contact d'un premier produit présent dans un contenant, avec un deuxième produit, dispositif et procédé associé |
FR2978900A1 (fr) * | 2011-08-11 | 2013-02-15 | Capsum | Capsules alimentaires |
WO2013113855A2 (fr) | 2012-01-31 | 2013-08-08 | Capsum | Capsules contenant des cellules de mammifères |
WO2013132082A1 (fr) | 2012-03-08 | 2013-09-12 | Capsum | Kit comprenant deux compositions séparées, notamment pour une application cosmétique |
CN103635252A (zh) * | 2011-03-08 | 2014-03-12 | 卡普苏姆公司 | 形成分散在与第一相基本不混溶的第二相中的第一相液滴的方法 |
WO2015075074A1 (fr) | 2013-11-19 | 2015-05-28 | Capsum | Procédé de préparation de capsules comprenant un coeur liquide et une coque externe |
WO2015086832A1 (fr) * | 2013-12-13 | 2015-06-18 | Etablissement Français Du Sang | Capsules contenant des cellules à potentialité hématopoïétique |
WO2016062836A1 (fr) | 2014-10-22 | 2016-04-28 | Capsum | Capsule gélifiée comprenant une cellule végétale |
US9446425B2 (en) | 2012-08-16 | 2016-09-20 | Capsum | Element for delivering a fluid composition, associated dispensing device and associated method |
EP3100786A1 (fr) * | 2010-07-22 | 2016-12-07 | Gencell Biosystems Limited | Cellules de liquide composite |
WO2017046305A1 (fr) | 2015-09-18 | 2017-03-23 | Capsum | Dispersions stables de gouttes comprenant un agent gelifiant |
WO2017046299A1 (fr) | 2015-09-18 | 2017-03-23 | Capsum | Emulsions stables de gouttes à écorce polymérique |
US9776182B2 (en) | 2012-11-27 | 2017-10-03 | Gencell Biosystems Ltd. | Handling liquid samples |
WO2017207645A1 (fr) | 2016-06-01 | 2017-12-07 | Capsum | Dispositif de conditionnement et de distribution d'une composition, notamment cosmétique, résultant de la mise en oeuvre d'au moins deux compositions |
WO2018015197A1 (fr) | 2016-07-20 | 2018-01-25 | Capsum | Série de capsules et procédé de fabrication, composition cosmétique et traitement cosmétique |
CN107929077A (zh) * | 2017-11-28 | 2018-04-20 | 宁波明佳汽车内饰有限公司 | 一种软胶囊成型方法 |
WO2018077977A1 (fr) | 2016-10-26 | 2018-05-03 | Capsum | Émulsions doubles comprenant une phase grasse gélifiée |
WO2018077986A1 (fr) | 2016-10-26 | 2018-05-03 | Capsum | Émulsions doubles avec double coacervat |
EP3321352A1 (fr) | 2016-11-09 | 2018-05-16 | Biomillenia SAS | Système de sélection auxotrophique |
WO2018138271A1 (fr) | 2017-01-26 | 2018-08-02 | Biomillenia Sas | Criblage microfluidique à haut débit dans des gouttelettes |
WO2018158450A1 (fr) | 2017-03-03 | 2018-09-07 | Biomillenia Sas | Microparticule destinée à cultiver et tester des cellules |
WO2018178353A1 (fr) | 2017-03-30 | 2018-10-04 | Capsum | Particules colorées à teneur élevée en pigment |
WO2018178365A1 (fr) | 2017-03-30 | 2018-10-04 | Sensient Cosmetic Technologies | Particules colorées à teneur élevée en pigment |
WO2019002579A1 (fr) | 2017-06-30 | 2019-01-03 | Capsum | Composition triphasique |
WO2019053236A1 (fr) | 2017-09-14 | 2019-03-21 | Capsum | Dispersion avec phase grasse dispersee à teneur élevée en pigments |
WO2019057914A1 (fr) | 2017-09-22 | 2019-03-28 | Capsum | Capsules bactericides ou bactériostatiques ou antifongiques comprenant des cellules vivantes et leurs utilisations |
WO2019092213A1 (fr) | 2017-11-09 | 2019-05-16 | Biomillenia Sas | Système de sélection microbienne |
WO2019115549A1 (fr) | 2017-12-11 | 2019-06-20 | Capsum | Méthode de criblage de séquences de conditions de culture |
WO2019145424A1 (fr) | 2018-01-24 | 2019-08-01 | Capsum | Dispositif de production d'une dispersion, ensemble et procédé associés |
US10384187B2 (en) | 2014-02-10 | 2019-08-20 | Gencell Biosystems Ltd | Composite liquid cell (CLC) mediated nucleic acid library preparation device, and methods for using the same |
WO2020039062A1 (fr) | 2018-08-23 | 2020-02-27 | Capsum | Dispositif de production d'une dispersion, ensemble et procédé associés |
FR3094232A1 (fr) | 2018-10-23 | 2020-10-02 | Capsum | Unite de fabrication d’un extrait d’interet d’au moins un vegetal, microorganisme et/ou champignon |
WO2021234135A1 (fr) | 2020-05-21 | 2021-11-25 | Capsum | Dispersion stable sans écorce |
WO2021234134A1 (fr) | 2020-05-21 | 2021-11-25 | Capsum | Emulsion double stable sans écorce |
WO2022096699A1 (fr) | 2020-11-09 | 2022-05-12 | Capsum | Appareil de décontamination d'un objet creux définissant une cavité interne, machine de distribution et procédé associés |
FR3119317A1 (fr) | 2021-02-04 | 2022-08-05 | Capsum | Composition sous forme d’émulsion macroscopique stable comprenant un pourcentage d’ingrédients d’origine naturelle supérieur ou égale à 95% selon la norme ISO 16128 |
FR3129287A1 (fr) | 2021-11-24 | 2023-05-26 | Capsum | Dispersion macroscopique avec phase grasse dispersee à teneur élevée en polymere cationique et en pigments |
FR3129286A1 (fr) | 2021-11-24 | 2023-05-26 | Capsum | Dispersion macroscopique |
FR3129590A1 (fr) | 2021-11-26 | 2023-06-02 | Capsum | Dispersion macroscopique solaire sans écorce |
WO2023099661A1 (fr) | 2021-12-01 | 2023-06-08 | Vilnius University | Microcapsules comprenant des échantillons biologiques, et leurs procédés d'utilisation |
WO2023117364A1 (fr) | 2021-12-01 | 2023-06-29 | Vilnius University | Microcapsule et procédés de fabrication et d'utilisation de celle-ci |
FR3134714A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide comprenant au moins une cavité |
FR3134715A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide solaire comprenant au moins une cavité |
FR3134718A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique parfumante solide comprenant au moins une cavité |
FR3134716A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide de maquillage comprenant au moins une cavité |
FR3134717A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide de soin comprenant au moins une cavité |
FR3136157A1 (fr) | 2022-06-02 | 2023-12-08 | Capsum | Procédé simplifié de préparation d’une émulsion double |
FR3136963A1 (fr) | 2022-06-28 | 2023-12-29 | Capsum | Composition cosmétique solide de soin capillaire comprenant au moins une cavité |
FR3137107A1 (fr) | 2022-06-28 | 2023-12-29 | Capsum | Composition de nettoyage solide comprenant au moins une cavité |
WO2024003265A1 (fr) | 2022-06-30 | 2024-01-04 | Lesaffre Et Compagnie | Microcapsule comprenant un bactériophage |
FR3141856A1 (fr) | 2022-11-14 | 2024-05-17 | Capsum | Composition solide comprenant au moins une cavité comprenant au moins une phase gélifiée aqueuse et/ou grasse |
FR3141854A1 (fr) | 2022-11-14 | 2024-05-17 | Capsum | Composition solide comprenant au moins une cavité et au moins une matière première hydrophile incompatible et/ou instable |
WO2024115736A1 (fr) | 2022-12-01 | 2024-06-06 | Capsum | Composition solide non pulvérulente comprenant au moins 8% en poids d'agent(s) désintégrant(s) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2964017B1 (fr) * | 2010-09-01 | 2013-05-31 | Capsum | Procede de fabrication d'une serie de capsules de taille submillimetrique |
FR2972371B1 (fr) * | 2011-03-08 | 2013-03-15 | Capsum | Procede de formation de gouttes d'une premiere phase dispersees dans une deuxieme phase sensiblement immiscible avec la premiere phase |
FR2976824B1 (fr) * | 2011-06-21 | 2013-08-02 | Capsum | Dispositif de formation de gouttes d'une phase interne dispersees dans une phase externe, ensemble et procede associes |
FR2987740B1 (fr) * | 2012-03-08 | 2014-04-18 | Capsum | Dispersion destinee a encapsuler un produit actif et utilisation associee |
FR3012050B1 (fr) * | 2013-10-17 | 2016-01-01 | Capsum | Procede de formation d'une dispersion comprenant des gouttes, et appareil associe |
FR3013218B1 (fr) * | 2013-11-18 | 2016-07-29 | Capsum | Composition comprenant des capsules gelifiees stabilisees par un tampon |
FR3025437B1 (fr) * | 2014-09-04 | 2019-10-18 | Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris | Capsules a membrane conductrice |
EP3212321B1 (fr) | 2014-11-01 | 2020-06-24 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften | Microcapsules sphériques réfléchissante et leurs procédés de production |
GB201504222D0 (en) * | 2015-03-12 | 2015-04-29 | Dovetailed Ltd | Droplet assemblies and methods for producing droplet assemblies |
ES2540925B1 (es) * | 2015-05-27 | 2016-01-22 | Caviaroli, S.L. | Procedimiento de encapsulación de sustancias hidrófobas |
FR3047012B1 (fr) * | 2016-01-26 | 2020-07-31 | Ecole Superieure Physique & Chimie Ind Ville De Paris | Microcapsule de cellules primaires |
ES2595243B1 (es) * | 2016-09-16 | 2017-04-06 | Caviaroli, S.L. | Procedimiento de envasado de capsulas alimenticias y producto alimenticio envasado obtenido mediante el mismo |
US10719999B2 (en) * | 2017-04-27 | 2020-07-21 | Schlage Lock Company Llc | Technologies for determining intent in an access control system |
CN107361392B (zh) * | 2017-07-26 | 2019-10-25 | 云南芯韵科技开发有限公司 | 一种三层含水胶囊及其制备方法 |
CN109419628A (zh) * | 2017-09-04 | 2019-03-05 | 烟台百药泰中药科技有限公司 | 多孔无缝胶丸滴头 |
FR3072026B1 (fr) * | 2017-10-10 | 2019-10-25 | Capsum | Ensembles de particules, procedes de preparation et kits les comprenant |
CN107929076B (zh) * | 2017-11-28 | 2021-03-09 | 宁波明佳汽车内饰有限公司 | 一种用于软胶囊成型的设备 |
CN108272744A (zh) * | 2018-04-26 | 2018-07-13 | 北京婼薇乐护肤品有限公司 | 一种胶囊精华液及制造该胶囊精华液的方法 |
CN108478446A (zh) * | 2018-05-11 | 2018-09-04 | 北京婼薇乐护肤品有限公司 | 一种胶囊面霜及制造该胶囊面霜的方法 |
CN108578258B (zh) * | 2018-05-30 | 2022-08-19 | 北京婼薇乐护肤品有限公司 | 一种胶囊精华露及制造该胶囊精华露的方法 |
WO2021002804A1 (fr) * | 2019-07-04 | 2021-01-07 | National University Of Singapore | Composites comestibles, procédés de formation et dispositifs associés |
CN110743634B (zh) * | 2019-09-20 | 2021-06-01 | 华南农业大学 | 一种微流控设备 |
CN111567868B (zh) * | 2020-05-19 | 2022-05-03 | 广西中烟工业有限责任公司 | 一种烟用爆珠制备装置及其应用 |
WO2022096294A2 (fr) | 2020-11-03 | 2022-05-12 | Droplet Genomics, Uab | Plateforme intégrée pour le traitement sélectif de particules microfluidiques |
WO2024003268A1 (fr) | 2022-06-30 | 2024-01-04 | Kapsera S.A.S. | Procédé de séchage de capsule |
WO2024003267A1 (fr) | 2022-06-30 | 2024-01-04 | Kapsera S.A.S. | Microcapsules contrôlant la diffusion d'un composé organique actif |
WO2024003266A1 (fr) | 2022-06-30 | 2024-01-04 | Kapsera S.A.S. | Microcapsules comprenant un filtre uv |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2192171A (en) * | 1986-06-06 | 1988-01-06 | Univ Ramot | Production of polymetric beads having alginate shells |
US5330835A (en) * | 1991-07-31 | 1994-07-19 | Morishita Jintan Co., Ltd. | Seamless capsule and process for producing the same |
US5650232A (en) * | 1994-10-07 | 1997-07-22 | Warner-Lambert Company | Method for making seamless capsules |
US6056992A (en) | 1988-06-02 | 2000-05-02 | Campbell Soup Company | Encapsulated additives |
EP1310229A1 (fr) * | 2000-08-17 | 2003-05-14 | Chugai Seiyaku Kabushiki Kaisha | Procede de fabrication de capsule sans soudure |
WO2006136196A1 (fr) * | 2005-06-21 | 2006-12-28 | V. Mane Fils | Capsule de gellane sans joint pouvant etre cassee et son procede de fabrication |
US20070145326A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Microencapsulated heat delivery vehicles |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL169852C (nl) * | 1952-05-26 | Rapistan Van Der Lande Bv | Transportinrichting. | |
US3423489A (en) * | 1966-11-01 | 1969-01-21 | Minnesota Mining & Mfg | Encapsulation process |
US3779942A (en) * | 1970-12-04 | 1973-12-18 | Minnesota Mining & Mfg | Capsules and process for forming capsules |
GB1484562A (en) * | 1973-01-23 | 1977-09-14 | Unilever Ltd | Process for preparing encapsulated drops of fruit materia |
US4764317A (en) * | 1984-02-09 | 1988-08-16 | Southwest Research Institute | Microencapsulation process and apparatus |
US6325859B1 (en) * | 1996-10-09 | 2001-12-04 | Givaudan Roure (International) Sa | Process for preparing beads as food or tobacco additive |
EP1355537A4 (fr) * | 2001-01-31 | 2010-04-07 | Kraft Foods Global Brands Llc | Production de capsules et de particules pour ameliorer des produits alimentaires |
DE10164110A1 (de) * | 2001-12-24 | 2003-07-10 | Dragoco Gerberding Co Ag | Mononuklear gefüllte Mikrokapseln |
-
2008
- 2008-12-01 FR FR0858172A patent/FR2939012B1/fr active Active
-
2009
- 2009-12-01 WO PCT/FR2009/052351 patent/WO2010063937A1/fr active Application Filing
- 2009-12-01 EP EP09801470.7A patent/EP2370066B1/fr active Active
- 2009-12-01 CN CN200980156111.9A patent/CN102300564B/zh active Active
- 2009-12-01 US US13/131,971 patent/US9277759B2/en active Active
- 2009-12-01 BR BRPI0916506A patent/BRPI0916506A8/pt not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2192171A (en) * | 1986-06-06 | 1988-01-06 | Univ Ramot | Production of polymetric beads having alginate shells |
US6056992A (en) | 1988-06-02 | 2000-05-02 | Campbell Soup Company | Encapsulated additives |
US5330835A (en) * | 1991-07-31 | 1994-07-19 | Morishita Jintan Co., Ltd. | Seamless capsule and process for producing the same |
US5650232A (en) * | 1994-10-07 | 1997-07-22 | Warner-Lambert Company | Method for making seamless capsules |
EP1310229A1 (fr) * | 2000-08-17 | 2003-05-14 | Chugai Seiyaku Kabushiki Kaisha | Procede de fabrication de capsule sans soudure |
WO2006136196A1 (fr) * | 2005-06-21 | 2006-12-28 | V. Mane Fils | Capsule de gellane sans joint pouvant etre cassee et son procede de fabrication |
US20070145326A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Microencapsulated heat delivery vehicles |
Cited By (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3100786A1 (fr) * | 2010-07-22 | 2016-12-07 | Gencell Biosystems Limited | Cellules de liquide composite |
US10125389B2 (en) | 2010-07-22 | 2018-11-13 | Gencell Biosystems Limited | Composite liquid cells |
US20140011033A1 (en) * | 2010-12-31 | 2014-01-09 | Capsum | Series of capsules comprising at least one drop of internal phase in a drop of intermediate phase and manufacturing method thereof |
FR2969907A1 (fr) * | 2010-12-31 | 2012-07-06 | Capsum | Serie de capsules comprenant au moins une goutte de phase interne dans une goutte de phase intermediaire et procede de fabrication associe |
WO2012089820A1 (fr) | 2010-12-31 | 2012-07-05 | Capsum | Serie de capsules comprenant au moins une goutte de phase interne dans une goutte de phase intermediaire et procede de fabrication associe |
US10350567B2 (en) * | 2010-12-31 | 2019-07-16 | Capsum | Series of capsules comprising at least one drop of internal phase in a drop of intermediate phase and manufacturing method thereof |
CN103491808A (zh) * | 2010-12-31 | 2014-01-01 | 凯普萨姆公司 | 在中间相的液滴中包括内相的至少一个液滴的胶囊系列及相关制造方法 |
CN103635252A (zh) * | 2011-03-08 | 2014-03-12 | 卡普苏姆公司 | 形成分散在与第一相基本不混溶的第二相中的第一相液滴的方法 |
FR2973356A1 (fr) * | 2011-03-31 | 2012-10-05 | Capsum | Module de mise en contact d'un premier produit present dans un contenant, avec un deuxieme produit, dispositif et procede associe |
WO2012131043A1 (fr) | 2011-03-31 | 2012-10-04 | Capsum | Module de mise en contact d'un premier produit présent dans un contenant, avec un deuxième produit, dispositif et procédé associé |
FR2978900A1 (fr) * | 2011-08-11 | 2013-02-15 | Capsum | Capsules alimentaires |
WO2013113855A2 (fr) | 2012-01-31 | 2013-08-08 | Capsum | Capsules contenant des cellules de mammifères |
WO2013132082A1 (fr) | 2012-03-08 | 2013-09-12 | Capsum | Kit comprenant deux compositions séparées, notamment pour une application cosmétique |
US9446425B2 (en) | 2012-08-16 | 2016-09-20 | Capsum | Element for delivering a fluid composition, associated dispensing device and associated method |
US10252261B2 (en) | 2012-11-27 | 2019-04-09 | Gencell Biosystems Ltd. | Handling liquid samples |
US9776182B2 (en) | 2012-11-27 | 2017-10-03 | Gencell Biosystems Ltd. | Handling liquid samples |
WO2015075074A1 (fr) | 2013-11-19 | 2015-05-28 | Capsum | Procédé de préparation de capsules comprenant un coeur liquide et une coque externe |
FR3014691A1 (fr) * | 2013-12-13 | 2015-06-19 | Ets Francais Du Sang | Capsules contenant des cellules a potentialite hematopoietique |
WO2015086832A1 (fr) * | 2013-12-13 | 2015-06-18 | Etablissement Français Du Sang | Capsules contenant des cellules à potentialité hématopoïétique |
US10384187B2 (en) | 2014-02-10 | 2019-08-20 | Gencell Biosystems Ltd | Composite liquid cell (CLC) mediated nucleic acid library preparation device, and methods for using the same |
WO2016062836A1 (fr) | 2014-10-22 | 2016-04-28 | Capsum | Capsule gélifiée comprenant une cellule végétale |
EP3718530A1 (fr) | 2014-10-22 | 2020-10-07 | Capsum | Capsule gélifiée comprenant une cellule végétale |
US11077032B2 (en) | 2015-09-18 | 2021-08-03 | Capsum | Stable dispersions containing drops comprising a gelling agent |
WO2017046299A1 (fr) | 2015-09-18 | 2017-03-23 | Capsum | Emulsions stables de gouttes à écorce polymérique |
WO2017046305A1 (fr) | 2015-09-18 | 2017-03-23 | Capsum | Dispersions stables de gouttes comprenant un agent gelifiant |
WO2017207645A1 (fr) | 2016-06-01 | 2017-12-07 | Capsum | Dispositif de conditionnement et de distribution d'une composition, notamment cosmétique, résultant de la mise en oeuvre d'au moins deux compositions |
US10940098B2 (en) | 2016-07-20 | 2021-03-09 | Capsum | Series of capsules and method of manufacture, cosmetic composition and cosmetic treatment |
WO2018015197A1 (fr) | 2016-07-20 | 2018-01-25 | Capsum | Série de capsules et procédé de fabrication, composition cosmétique et traitement cosmétique |
WO2018077977A1 (fr) | 2016-10-26 | 2018-05-03 | Capsum | Émulsions doubles comprenant une phase grasse gélifiée |
WO2018077986A1 (fr) | 2016-10-26 | 2018-05-03 | Capsum | Émulsions doubles avec double coacervat |
WO2018087259A1 (fr) | 2016-11-09 | 2018-05-17 | Biomillenia Sas | Système de sélection auxotrophe |
EP3321352A1 (fr) | 2016-11-09 | 2018-05-16 | Biomillenia SAS | Système de sélection auxotrophique |
WO2018138271A1 (fr) | 2017-01-26 | 2018-08-02 | Biomillenia Sas | Criblage microfluidique à haut débit dans des gouttelettes |
WO2018158450A1 (fr) | 2017-03-03 | 2018-09-07 | Biomillenia Sas | Microparticule destinée à cultiver et tester des cellules |
WO2018178353A1 (fr) | 2017-03-30 | 2018-10-04 | Capsum | Particules colorées à teneur élevée en pigment |
WO2018178365A1 (fr) | 2017-03-30 | 2018-10-04 | Sensient Cosmetic Technologies | Particules colorées à teneur élevée en pigment |
CN110662527A (zh) * | 2017-03-30 | 2020-01-07 | 卡普苏姆公司 | 具有高颜料含量的有色颗粒 |
WO2019002579A1 (fr) | 2017-06-30 | 2019-01-03 | Capsum | Composition triphasique |
US11944698B2 (en) | 2017-09-14 | 2024-04-02 | Capsum | Dispersion with a dispersed fatty phase having a high pigment content |
WO2019053236A1 (fr) | 2017-09-14 | 2019-03-21 | Capsum | Dispersion avec phase grasse dispersee à teneur élevée en pigments |
WO2019057914A1 (fr) | 2017-09-22 | 2019-03-28 | Capsum | Capsules bactericides ou bactériostatiques ou antifongiques comprenant des cellules vivantes et leurs utilisations |
WO2019092213A1 (fr) | 2017-11-09 | 2019-05-16 | Biomillenia Sas | Système de sélection microbienne |
CN107929077A (zh) * | 2017-11-28 | 2018-04-20 | 宁波明佳汽车内饰有限公司 | 一种软胶囊成型方法 |
WO2019115549A1 (fr) | 2017-12-11 | 2019-06-20 | Capsum | Méthode de criblage de séquences de conditions de culture |
WO2019145424A1 (fr) | 2018-01-24 | 2019-08-01 | Capsum | Dispositif de production d'une dispersion, ensemble et procédé associés |
FR3085121A1 (fr) | 2018-08-23 | 2020-02-28 | Capsum | Dispositif de production d'une dispersion, ensemble et procede associes |
WO2020039062A1 (fr) | 2018-08-23 | 2020-02-27 | Capsum | Dispositif de production d'une dispersion, ensemble et procédé associés |
FR3094232A1 (fr) | 2018-10-23 | 2020-10-02 | Capsum | Unite de fabrication d’un extrait d’interet d’au moins un vegetal, microorganisme et/ou champignon |
WO2021234135A1 (fr) | 2020-05-21 | 2021-11-25 | Capsum | Dispersion stable sans écorce |
WO2021234134A1 (fr) | 2020-05-21 | 2021-11-25 | Capsum | Emulsion double stable sans écorce |
FR3110406A1 (fr) | 2020-05-21 | 2021-11-26 | Capsum | Dispersion stable sans écorce |
FR3110405A1 (fr) | 2020-05-21 | 2021-11-26 | Capsum | Emulsion double stable sans écorce |
WO2022096699A1 (fr) | 2020-11-09 | 2022-05-12 | Capsum | Appareil de décontamination d'un objet creux définissant une cavité interne, machine de distribution et procédé associés |
FR3115995A1 (fr) | 2020-11-09 | 2022-05-13 | Capsum | Appareil de décontamination d’un objet creux définissant une cavité interne, machine de distribution et procédé associés |
WO2022167567A1 (fr) | 2021-02-04 | 2022-08-11 | Capsum | Composition sous forme d'émulsion macroscopique stable comprenant un pourcentage d'ingrédients d'origine naturelle supérieur ou égale à 95% selon la norme iso 16128 |
FR3119317A1 (fr) | 2021-02-04 | 2022-08-05 | Capsum | Composition sous forme d’émulsion macroscopique stable comprenant un pourcentage d’ingrédients d’origine naturelle supérieur ou égale à 95% selon la norme ISO 16128 |
FR3129287A1 (fr) | 2021-11-24 | 2023-05-26 | Capsum | Dispersion macroscopique avec phase grasse dispersee à teneur élevée en polymere cationique et en pigments |
FR3129286A1 (fr) | 2021-11-24 | 2023-05-26 | Capsum | Dispersion macroscopique |
WO2023094406A1 (fr) | 2021-11-24 | 2023-06-01 | Capsum | Dispersion macroscopique avec phase grasse dispersée à teneur élevée en polymère cationique et en pigments |
WO2023094468A1 (fr) | 2021-11-24 | 2023-06-01 | Capsum | Dispersion macroscopique sans écorce avec phase grasse pigmentee |
FR3129590A1 (fr) | 2021-11-26 | 2023-06-02 | Capsum | Dispersion macroscopique solaire sans écorce |
WO2023099661A1 (fr) | 2021-12-01 | 2023-06-08 | Vilnius University | Microcapsules comprenant des échantillons biologiques, et leurs procédés d'utilisation |
WO2023117364A1 (fr) | 2021-12-01 | 2023-06-29 | Vilnius University | Microcapsule et procédés de fabrication et d'utilisation de celle-ci |
FR3134718A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique parfumante solide comprenant au moins une cavité |
FR3134715A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide solaire comprenant au moins une cavité |
FR3134716A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide de maquillage comprenant au moins une cavité |
FR3134717A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide de soin comprenant au moins une cavité |
WO2023209019A1 (fr) | 2022-04-26 | 2023-11-02 | Capsum | Composition cosmétique solide comprenant au moins une cavité |
WO2023209015A1 (fr) | 2022-04-26 | 2023-11-02 | Capsum | Composition cosmétique solide de maquillage comprenant au moins une cavité |
WO2023209011A1 (fr) | 2022-04-26 | 2023-11-02 | Capsum | Composition cosmétique solide solaire comprenant au moins une cavité |
WO2023208985A1 (fr) | 2022-04-26 | 2023-11-02 | Capsum | Composition cosmétique parfumante solide comprenant au moins une cavité |
WO2023209021A1 (fr) | 2022-04-26 | 2023-11-02 | Capsum | Composition cosmétique solide de soin comprenant au moins une cavité |
FR3134714A1 (fr) | 2022-04-26 | 2023-10-27 | Capsum | Composition cosmétique solide comprenant au moins une cavité |
FR3136157A1 (fr) | 2022-06-02 | 2023-12-08 | Capsum | Procédé simplifié de préparation d’une émulsion double |
FR3137107A1 (fr) | 2022-06-28 | 2023-12-29 | Capsum | Composition de nettoyage solide comprenant au moins une cavité |
WO2024003065A1 (fr) | 2022-06-28 | 2024-01-04 | Capsum | Composition de nettoyage solide comprenant au moins une cavité |
WO2024003116A1 (fr) | 2022-06-28 | 2024-01-04 | Capsum | Composition cosmétique solide de soin capillaire comprenant au moins une cavité |
FR3136963A1 (fr) | 2022-06-28 | 2023-12-29 | Capsum | Composition cosmétique solide de soin capillaire comprenant au moins une cavité |
WO2024003265A1 (fr) | 2022-06-30 | 2024-01-04 | Lesaffre Et Compagnie | Microcapsule comprenant un bactériophage |
FR3141856A1 (fr) | 2022-11-14 | 2024-05-17 | Capsum | Composition solide comprenant au moins une cavité comprenant au moins une phase gélifiée aqueuse et/ou grasse |
FR3141854A1 (fr) | 2022-11-14 | 2024-05-17 | Capsum | Composition solide comprenant au moins une cavité et au moins une matière première hydrophile incompatible et/ou instable |
WO2024105008A1 (fr) | 2022-11-14 | 2024-05-23 | Capsum | Composition solide comprenant au moins une cavité comprenant au moins une phase gélifiée aqueuse et/ou grasse |
WO2024105012A1 (fr) | 2022-11-14 | 2024-05-23 | Capsum | Composition solide comprenant au moins une cavité et au moins une matière première hydrophile incompatible et/ou instable |
WO2024115736A1 (fr) | 2022-12-01 | 2024-06-06 | Capsum | Composition solide non pulvérulente comprenant au moins 8% en poids d'agent(s) désintégrant(s) |
FR3142667A1 (fr) | 2022-12-01 | 2024-06-07 | Capsum | Composition solide non pulvérulente comprenant au moins 8% en poids d’agent(s) désintégrant |
Also Published As
Publication number | Publication date |
---|---|
CN102300564A (zh) | 2011-12-28 |
FR2939012A1 (fr) | 2010-06-04 |
EP2370066B1 (fr) | 2016-03-30 |
US20120003285A1 (en) | 2012-01-05 |
CN102300564B (zh) | 2014-12-10 |
EP2370066A1 (fr) | 2011-10-05 |
US9277759B2 (en) | 2016-03-08 |
FR2939012B1 (fr) | 2015-03-27 |
BRPI0916506A2 (pt) | 2015-11-10 |
BRPI0916506A8 (pt) | 2018-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2370066B1 (fr) | Procede de fabrication d'une serie de capsules, et serie de capsules associee | |
WO2012089820A1 (fr) | Serie de capsules comprenant au moins une goutte de phase interne dans une goutte de phase intermediaire et procede de fabrication associe | |
EP3057699B1 (fr) | Procédé de formation d'une dispersion comprenant des gouttes, et appareil associé | |
FR2964017A1 (fr) | Procede de fabrication d'une serie de capsules de taille submillimetrique | |
EP3487476B1 (fr) | Série de capsules et procédé de fabrication, composition cosmétique et traitement cosmétique | |
WO2013113830A1 (fr) | Procédé de préparation de capsules rigidifiées | |
EP2885085A1 (fr) | Elément de délivrance d'une composition fluide, dispositif de distribution et procédé associés | |
EP2822530A1 (fr) | Kit comprenant deux compositions séparées, notamment pour une application cosmétique | |
WO2011086331A2 (fr) | Procédé de fabrication de capsules avec une hauteur de chute contrôlée. | |
WO2012120043A2 (fr) | Procédé de formation de gouttes d'une première phase dispersées dans une deuxième phase sensiblement immiscible avec la première phase | |
EP3071169A1 (fr) | Composition comprenant des capsules gélifiées stabilisées par un tampon | |
WO2013132083A1 (fr) | Dispersion comprenant des corps dispersés, chacun comportant une goutte interne et une membrane | |
EP3057698B1 (fr) | Dispositif de production d'éléments dispersés, ensemble et procédé de production associés | |
WO2012131043A1 (fr) | Module de mise en contact d'un premier produit présent dans un contenant, avec un deuxième produit, dispositif et procédé associé | |
FR3013233A1 (fr) | Procede de preparation de capsules comprenant un coeur liquide et une coque externe | |
FR3086866A1 (fr) | Kit comprenant deux compositions separees, notamment pour une application cosmetique | |
EP2809351B1 (fr) | Procédé de préparation d'un produit sirupeux comprenant des vitamines | |
WO2014195268A1 (fr) | Vanne à boisseau, dispositif de dosage d'un fluide et procédé de dosage associés | |
FR2996752A1 (fr) | Utilisation de de billes cosmetiques, emballage et billes cosmetiques associes. | |
FR2978900A1 (fr) | Capsules alimentaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980156111.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09801470 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009801470 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13131971 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0916506 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110531 |